Novavax to Present at the Wedbush PacGrow Healthcare Conference

GAITHERSBURG, Md., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the Wedbush PacGrow Healthcare Conference.

Conference details are as follows:

Date: Wednesday, August 12, 2015Time: 12:45 p.m. US Eastern Time Location: Le Parker Meridian hotel, New York City Live webcast: http://wsw.com/webcast/wedbush30/nvax

The webcast and a replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website, novavax.com.

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations

[email protected]
240-268-2000
 
Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.

[email protected]
[email protected]
212-845-4271

You May Also Be Interested In

• Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8%
• JetAlto Challenges Charter Brokers to Show Prices Before Asking for Phone Numbers
• AM Best Affirms Credit Ratings of Lloyd’s Syndicates 623, 2623, 3623 and 3622